Sacral Neuromodulation for Neurogenic Lower Urinary Tract, Bowel and Sexual Dysfunction
NCT: NCT05380856 · RECRUITING
Brief Summary
A multi-center double-blinded placebo-controlled randomized clinical trial. The patients will be randomized into two groups. To investigate the efficacy of SNM to improve the key bladder diary variables compared to placebo (i.e. sham) for patients with MS having refractory neurogenic lower urinary tract dysfunction (NLUTD). After first step SNM-procedure and a 3-4 weeks test period patients with more than 50% improvement in the key bladder diary variables will have the IPG implanted. After a month of optimization patients will into two groups: IPG ON or IPG OFF. Period of randomization: four months. Number anticipated to be included: 60 patients
Frequently Asked Questions
What is Sacral Neuromodulation for Neurogenic Lower Urinary Tract, Bowel and Sexual Dysfunction?
Sacral Neuromodulation for Neurogenic Lower Urinary Tract, Bowel and Sexual Dysfunction is a clinical trial registered under NCT05380856. Current status: RECRUITING.
What is the status of NCT05380856?
The current status of NCT05380856 (Sacral Neuromodulation for Neurogenic Lower Urinary Tract, Bowel and Sexual Dysfunction) is: RECRUITING.
When did Sacral Neuromodulation for Neurogenic Lower Urinary Tract, Bowel and Sexual Dysfunction start?
Sacral Neuromodulation for Neurogenic Lower Urinary Tract, Bowel and Sexual Dysfunction started on 2023-09-26.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.